Concerns about Patient Access to Biopharmaceuticals and Outcomes
A survey of the NEJM Catalyst Insights Council finds strong support globally for government regulation of biopharmaceutical prices.
A survey of the NEJM Catalyst Insights Council finds strong support globally for government regulation of biopharmaceutical prices.
The COVID-19 pandemic dramatically reshaped the labor market, especially for service sector workers.
We study how to admit and schedule heterogeneous patients by using simple, interpretable, yet effective policies when capacity is scarce, no-show behavior is patient- and time-dependent, service durat
People with important evidence-based ideas often struggle to translate data into stories their readers can relate to and understand.
Concerns have been raised about the “demise of democracy”, possibly accelerated by pandemic-related restrictions.
This book collects the main papers written by George Borjas on the economics of immigration during a decades-long career.
Over 2009-2019 the seemingly inexorable rise in health care’s share of GDP markedly slowed, both in the US and elsewhere.
Incomplete health insurance enrollment is a persistent U.S. challenge despite large subsidies. We ask whether hassles built into enrollment systems matter for insurance take-up and targeting.
Many older Americans do not receive needed care for mental health and substance use disorders (MHSUD), and there are substantial racial and ethnic disparities in receipt of this care across the lifesp
Hospitals play a key role in patient outcomes and spending, but efforts to improve their quality are hindered because we do not know whether hospital quality indicators are causal or biased.
Get smart & reliable public policy insights right in your inbox.